Copper Peptide GHK-Cu
GHK-Cu serves as a “genomic architect” for the skin, capable of resetting the expression of over 4,000 genes to a more regenerative state. Its clinical value at Creative Touch lies in its dual-action matrix management: it simultaneously signals for new collagen synthesis while upregulating the enzymatic “cleanup” of damaged, glycated tissue. This makes it an essential baseline for ” Collagen Banking” and post-procedure recovery, provided it is managed within the correct pH window to prevent ion dissociation.
GHK-Cu (Glycyl-L-histidyl-L-lysine-copper) is a naturally occurring tripeptide that functions as a critical signalling molecule in human tissue. It is highly age-dependent: plasma levels decline from ~200 ng/mL at age 20 to ~80 ng/mL by age 60, a drop of over 60% that correlates directly with reduced healing capacity and skin thinning. [1]
The Genomic Reset: Epigenetic Reprogramming
Unlike traditional peptides that serve as simple “messengers,” GHK-Cu acts at the genomic level. Broad Institute Connectivity Map data indicates that GHK can modulate the expression of 4,192 human genes. [6] It shifts the cellular pattern from a pro-inflammatory/aged profile toward a youthful/regenerative one, specifically by upregulating DNA repair genes and antioxidant enzymes like superoxide dismutase (SOD).
Matrix Remodelling: The MMP-2 vs. TIMP-1 Balance
A unique feature of GHK-Cu is its ability to manage the “biological housekeeping” of the dermis. In mature or photo-damaged skin, the extracellular matrix (ECM) often contains fragmented collagen that impedes new growth. GHK-Cu addresses this by modulating the ratio of Matrix Metalloproteinases (MMPs) to their inhibitors (TIMPs). [8]
- MMP-2 Upregulation: It increases the enzymes responsible for clearing out degraded, cross-linked proteins.
- TIMP-1 & 2 Support: It simultaneously increases the “brakes” that prevent over-degradation of healthy tissue. This ensures that “remodelling” is constructive – creating a clean, organised structural scaffold rather than just adding bulk to a dysfunctional matrix.
Inflammatory Suppression & Stemness
GHK-Cu creates a hospitable environment for regeneration by suppressing pro-inflammatory cytokines such as IL-6 and TNF-alpha. [4] By quieting the NF-κB pathway, it reduces the “biological noise” that often stalls professional treatment results. Furthermore, it increases markers of “stemness” (p63 and integrins) in basal keratinocytes, boosting the skin’s innate ability to renew its surface layer and maintain a resilient barrier. [5]
Clinical Application
At Creative Touch, GHK-Cu is positioned as a “Regenerative Baseline” – the agent that prepares the skin to respond effectively to more intensive stimuli like iPRF or Polynucleotides.
Strategic Timing: The “Cleanup” Phase
GHK-Cu is most rationally applied during the “proliferative phase” of wound healing. Following RF Microneedling or Thulium Laser, the skin must remove thermally damaged tissue before new collagen fibrils can be organised. GHK-Cu accelerates this transition, leading to faster re-epithelialisation and a more refined texture than post-procedure occlusion alone. [7]
The pH/Vitamin C Formulation Conflict
A critical insight for client safety is the pH-dependency of GHK-Cu. The copper ion is only loosely complexed with the GHK peptide; in environments with a pH below 5.0 (such as those created by L-Ascorbic Acid/Vitamin C), the copper ion dissociates. [2]
- Risk: Once dissociated, free copper can trigger a Fenton reaction, producing hydroxyl radicals that cause oxidative damage, the exact opposite of the intended goal.
- Advice: We recommend a “split routine” (Vitamin C AM / GHK-Cu PM) to ensure both actives remain stable and effective.
Addressing the “Copper Uglies”
The anecdotal “Copper Uglies” (sudden skin sagging) are biologically impossible at clinical concentrations. Scientific review suggests this phenomenon only occurs when non-physiological, high-percentage formulas are used without professional guidance, which can over-activate MMPs without sufficient TIMP inhibition. [3] Within the correct clinical protocol, GHK-Cu is used to restore the TIMP “brakes,” protecting structural integrity rather than compromising it.
References
Dou Y, Lee A, Zhu L, et al. (2020). The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther, 2(1), 58-61 . doi.org/10.31491/apt.2020.03.014
Jiang R, Sui Y, Hong J, et al. (2023). The Combined Administration of Vitamin C and Copper Induces a Systemic Oxidative Stress and Kidney Injury. Biomolecules, 13(1) . doi.org/10.3390/biom13010143
Ogórek K, Nowak K, Wadych E, et al. (2025). Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? Molecules, 30(1) . doi.org/10.3390/molecules30010136
Park JR, Lee H, Kim SI, et al. (2016). The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 7(36), 58405-58417 . doi.org/10.18632/oncotarget.11168
Pickart L, Vasquez-Soltero JM, Margolina A (2017). The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sci, 7(2) . doi.org/10.3390/brainsci7020020
Pickart L, Vasquez-Soltero JM, Margolina A (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int, 2015, 648108 . doi.org/10.1155/2015/648108
Sharma S, Anwar MF, Dinda A, et al. (2019). In Vitro and in Vivo Studies of pH-Sensitive GHK-Cu-Incorporated Polyaspartic and Polyacrylic Acid Superabsorbent Polymer. ACS Omega, 4(23), 20118-20128 . doi.org/10.1021/acsomega.9b00655
Siméon A, Emonard H, Hornebeck W, et al. (2000). The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci, 67(18), 2257-65 . doi.org/10.1016/s0024-3205(00)00803-1
Molecular Structure
- Formula
- C₁₄H₂₃CuN₆O₄+
- Weight
- 402.92 g/mol
- IUPAC
- copper (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate
Computational Identifiers
| InChI | InChI=1S/C14H24N6O4.Cu/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9;/h7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24);/q;+2/p-1/t10-,11-;/m0./s1 | |
|---|---|---|
| InChIKey | NZWIFMYRRCMYMN-ACMTZBLWSA-M | |
| Canonical SMILES | C1=C(NC=N1)CC(C(=O)NC(CCCCN)C(=O)[O-])NC(=O)CN.[Cu+2] | |
| Isomeric SMILES | C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)[O-])NC(=O)CN.[Cu+2] | |
Data sourced from: PubChem (NCBI) ↗ | ||
Also Known As
- copper peptide
- copper peptide (GHK-Cu)
- GHK-Cu
Learn More
This topic is discussed in 1 article:
